Development of a combined vaccine against equine influenza and tetanus. Experiment outside containment (clinical trial) for the study of the safety and efficacy of an intramuscular administration of recombinant canarypoxvirus expressing equine influenza v

Study title: 
Development of a combined vaccine against equine influenza and tetanus. Experiment outside containment (clinical trial) for the study of the safety and efficacy of an intramuscular administration of recombinant canarypoxvirus expressing equine influenza v
EU record number: 
B/BE/00/V15
Company / Sponsor: 
Merial
Treated organism: 
Horses
Indication category: 
vaccination against equine influenza virus
Genetic modification: 
haemagglutinin gene from equine influenza virus A2/Kentucky/94 or equine influenza virus A2/Newmarket/2/93
Method of transfer of nucleic acid of interest: 
Canarypoxvirus (ALVAC clone)
Route of administration: 
Intramuscular
Locations in Belgium: 
Gentbrugge and Bornem
Nr of subjects: 
50
Foreseen duration: 
12 months
Type of procedure: 
Deliberate release only

Information for the public

Information related to the decision procedure